A Powerful Way to
Take Control of Your
High Blood Pressure1

A Powerful Way to
Take Control of Your
High Blood Pressure1

If you’re not able to achieve your blood pressure goals, EDARBI® (azilsartan medoxomil) may be a good fit for you. EDARBI is an angiotensin II receptor blocker (ARB) proven to help lower blood pressure by relaxing your blood vessels.1 It may be prescribed alone or taken along with other medications used to treat high blood pressure.2

ARB, angiotensin II receptor blocker
Actor Portrayal

I’m not just 160/95.

I’m Shane.

Every day, people like you are taking control of their high blood pressure with EDARBI and EDARBYCLOR.
See Their Stories

EDARBI Controls Blood Pressure Better Than Similar Medications1

When scientists compared EDARBI with other medicines used to lower blood pressure, Benicar® (olmesartan) and Diovan® (valsartan), for 6 weeks, they found that EDARBI lowered blood pressure better.1*


22% greater reduction
than Benicar1*

(-14.3 mm Hg vs -11.7 mm Hg)

43% greater reduction
than Diovan1*

(-14.3 mm Hg vs -10.0 mm Hg)

This is important because millimeters matter.
Even a reduction of 2 to 5 mm Hg in your systolic blood pressure may lower your cardiovascular risk.3†

Proper medical treatment and control has been shown to lower the risk of dying
from heart-related problems such as heart attack and stroke.3

*Based on clinical trial data vs Diovan and Benicar, comparing 80 mg dose of EDARBI to 40 mg dose of Benicar and 320 mg dose of Diovan.1
†CV risk reduction with EDARBI and EDARBYCLOR has not been established.

See Study Design
EDARBI Safety and Tolerability
and Tolerability
Clinical studies of more than 4,800 people found that treatment
with EDARBI was well-tolerated with an overall incidence of
adverse reactions similar to placebo.2
Diarrhea in up to 2.0%.2
Some clinical trial participants (up to 0.4%) dropped out of the trial due to hypotension (blood pressure too low).2

Vomiting and diarrhea, a low salt diet, sweating a lot, or not drinking enough fluids can also lead to low blood pressure.4

If you are taking EDARBI and experience side effects that concern you, call your doctor for medical advice. You are encouraged to report side effects of prescription drugs to Azurity/Arbor Pharmaceuticals, LLC Medical Information at 1-866-516-4950 or to the FDA at www.fda.gov/medwatch or call 1-800-FDA-1088.

EDARBI Recommended Dosing
EDARBI Recommended

EDARBI is a once-daily oral medication taken
as initial or add-on therapy.2

  • May be administered with or without food.2
  • No dose titration is required.2
  • May be administered with other antihypertensive agents.2
  • Correct volume or salt depletion in patients prior to use.2
80 mg Once Daily
Recommended starting dose
40 mg Once Daily
Recommended dose for use with high doses of diuretics
Pills are not shown at actual size.

Lower Your BP Numbers, Lower Your Prescription Costs

Get the prescription treatment you need at a cost you can afford with our comprehensive suite of savings programs. Reach your goals by finding the savings program that works for you.
See savings opportunities

When you need a powerful combo

For high blood pressure that is not controlled with one medication, EDARBYCLOR is the only ARB fixed-dose combination with chlorthalidone.6 EDARBYCLOR has been proven superior to Benicar HCT® in head-to-head clinical trials.5
Learn about EDARBYCLOR

1. White WB, Weber MA, Sica D, et al. Effects of the angiotensin receptor blocker azilsartan medoxomil versus olmesartan and valsartan on ambulatory and clinic blood pressure in patients with stages 1 and 2 hypertension. Hypertension. 2011;57(3):413-420. doi:10.1161/HYPERTENSIONAHA.110.163402
2. Edarbi [package insert]. Atlanta, GA: Azurity/Arbor Pharmaceuticals, LLC; [2020].
3. Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension. 2018;71(6):1269-1324.
4. Low blood pressure — when blood pressure is too low. American Heart Association. Updated October 23, 2016. Accessed December 17, 2021. https://www.heart.org/en/health-topics/high-blood-pressure/the-facts-about-high-blood-pressure/low-blood-pressure-when-blood-pressure-is-too-low
5. Cushman WC, Bakris GL, White WB, et al. Azilsartan medoxomil plus chlorthalidone reduces blood pressure more effectively than olmesartan plus hydrochlorothiazide in stage 2 systolic hypertension. Hypertension. 2012;60(2):310-318.
6. Edarbyclor [package insert]. Atlanta, GA: Azurity/Arbor Pharmaceuticals, LLC; [2020].